Enlivex Therapeutics Ltd. (TLV:ENLV)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
335.00
-17.70 (-5.02%)
May 29, 2025, 5:24 PM IDT

Enlivex Therapeutics Market Cap

Enlivex Therapeutics has a market cap or net worth of 78.33 million as of May 30, 2025. Its market cap has decreased by -22.32% in one year.

Market Cap
78.33M
Enterprise Value
-2.10M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
335.00

Market Cap Chart

Since March 26, 2019, Enlivex Therapeutics's market cap has decreased from 368.04M to 78.33M, a decrease of -78.72%. That is a compound annual growth rate of -22.14%.

History

DateMarket Cap% Change
May 30, 202578.56M-16.17%
Dec 31, 202493.71M-48.18%
Dec 29, 2023180.84M-29.06%
Dec 30, 2022254.92M-28.46%
Dec 31, 2021356.33M-8.65%
Dec 31, 2020390.07M30.23%
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Teva Pharmaceutical Industries 73.03B
Danel (Adir Yeoshua) 2.39B
Kamada 1.39B
Bait Bakfar 1.13B
SofWave Medical 732.46M
Novolog (Pharm-Up 1966) 725.40M
BrainsWay 703.60M
Ilex Medical 683.03M
Market Cap Rankings